Cargando…
Exceptional in vivo catabolism of neurodegeneration-related aggregates
Neurodegenerative diseases are linked to a systemic enzyme resistance of toxic aggregated molecules and their pathological consequences. This paper presents a unique phenomenon that Philodina acuticornis, a bdelloid rotifer, is able to catabolize different types of neurotoxic peptide and protein agg...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789616/ https://www.ncbi.nlm.nih.gov/pubmed/29378654 http://dx.doi.org/10.1186/s40478-018-0507-3 |
_version_ | 1783296316480159744 |
---|---|
author | Datki, Zsolt Olah, Zita Hortobagyi, Tibor Macsai, Lilla Zsuga, Katalin Fulop, Livia Bozso, Zsolt Galik, Bence Acs, Eva Foldi, Angela Szarvas, Amanda Kalman, Janos |
author_facet | Datki, Zsolt Olah, Zita Hortobagyi, Tibor Macsai, Lilla Zsuga, Katalin Fulop, Livia Bozso, Zsolt Galik, Bence Acs, Eva Foldi, Angela Szarvas, Amanda Kalman, Janos |
author_sort | Datki, Zsolt |
collection | PubMed |
description | Neurodegenerative diseases are linked to a systemic enzyme resistance of toxic aggregated molecules and their pathological consequences. This paper presents a unique phenomenon that Philodina acuticornis, a bdelloid rotifer, is able to catabolize different types of neurotoxic peptide and protein aggregates (such as beta-amyloids /Aβ/, alpha-synuclein, and prion) without suffering any damage. P. acuticornis is capable of using these aggregates as an exclusive energy source (i.e., as ‘food’, identified in the digestive system and body) in a hermetically isolated microdrop environment, increasing their survival. As regards Aβ1–42, five other bdelloid rotifer species were also found to be able to perform this phenomenon. Based on our experiments, the Aβ1–42-treated bdelloid rotifers demonstrate significantly increased survival (e.g. mean lifespan = 51 ± 2.71 days) compared to their untreated controls (e.g. mean lifespan = 14 ± 2.29 days), with similar improvements in a variety of phenotypic characteristics. To our knowledge, no other animal species have so far been reported to have a similar capability. For all other microscopic species tested, including monogonant rotifers and non-rotifers, the treatment with Aβ1–42 aggregates proved to be either toxic or simply ineffective. This paper describes and proves the existence of an unprecedented in vivo catabolic capability of neurotoxic aggregates by bdelloid rotifers, with special focus on P. acuticornis. Our results may provide the basis for a new preclinical perspective on therapeutic research in human neurodegenerative diseases. |
format | Online Article Text |
id | pubmed-5789616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57896162018-02-08 Exceptional in vivo catabolism of neurodegeneration-related aggregates Datki, Zsolt Olah, Zita Hortobagyi, Tibor Macsai, Lilla Zsuga, Katalin Fulop, Livia Bozso, Zsolt Galik, Bence Acs, Eva Foldi, Angela Szarvas, Amanda Kalman, Janos Acta Neuropathol Commun Research Neurodegenerative diseases are linked to a systemic enzyme resistance of toxic aggregated molecules and their pathological consequences. This paper presents a unique phenomenon that Philodina acuticornis, a bdelloid rotifer, is able to catabolize different types of neurotoxic peptide and protein aggregates (such as beta-amyloids /Aβ/, alpha-synuclein, and prion) without suffering any damage. P. acuticornis is capable of using these aggregates as an exclusive energy source (i.e., as ‘food’, identified in the digestive system and body) in a hermetically isolated microdrop environment, increasing their survival. As regards Aβ1–42, five other bdelloid rotifer species were also found to be able to perform this phenomenon. Based on our experiments, the Aβ1–42-treated bdelloid rotifers demonstrate significantly increased survival (e.g. mean lifespan = 51 ± 2.71 days) compared to their untreated controls (e.g. mean lifespan = 14 ± 2.29 days), with similar improvements in a variety of phenotypic characteristics. To our knowledge, no other animal species have so far been reported to have a similar capability. For all other microscopic species tested, including monogonant rotifers and non-rotifers, the treatment with Aβ1–42 aggregates proved to be either toxic or simply ineffective. This paper describes and proves the existence of an unprecedented in vivo catabolic capability of neurotoxic aggregates by bdelloid rotifers, with special focus on P. acuticornis. Our results may provide the basis for a new preclinical perspective on therapeutic research in human neurodegenerative diseases. BioMed Central 2018-01-29 /pmc/articles/PMC5789616/ /pubmed/29378654 http://dx.doi.org/10.1186/s40478-018-0507-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Datki, Zsolt Olah, Zita Hortobagyi, Tibor Macsai, Lilla Zsuga, Katalin Fulop, Livia Bozso, Zsolt Galik, Bence Acs, Eva Foldi, Angela Szarvas, Amanda Kalman, Janos Exceptional in vivo catabolism of neurodegeneration-related aggregates |
title | Exceptional in vivo catabolism of neurodegeneration-related aggregates |
title_full | Exceptional in vivo catabolism of neurodegeneration-related aggregates |
title_fullStr | Exceptional in vivo catabolism of neurodegeneration-related aggregates |
title_full_unstemmed | Exceptional in vivo catabolism of neurodegeneration-related aggregates |
title_short | Exceptional in vivo catabolism of neurodegeneration-related aggregates |
title_sort | exceptional in vivo catabolism of neurodegeneration-related aggregates |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789616/ https://www.ncbi.nlm.nih.gov/pubmed/29378654 http://dx.doi.org/10.1186/s40478-018-0507-3 |
work_keys_str_mv | AT datkizsolt exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT olahzita exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT hortobagyitibor exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT macsaililla exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT zsugakatalin exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT fuloplivia exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT bozsozsolt exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT galikbence exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT acseva exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT foldiangela exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT szarvasamanda exceptionalinvivocatabolismofneurodegenerationrelatedaggregates AT kalmanjanos exceptionalinvivocatabolismofneurodegenerationrelatedaggregates |